PortfoliosLab logoPortfoliosLab logo
AUPH vs. CSCO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AUPH vs. CSCO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aurinia Pharmaceuticals Inc. (AUPH) and Cisco Systems, Inc. (CSCO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AUPH achieves a -0.82% return, which is significantly lower than CSCO's 58.91% return. Both investments have delivered pretty close results over the past 10 years, with AUPH having a 18.49% annualized return and CSCO not far ahead at 18.92%.


AUPH

1D
-0.19%
1M
-1.31%
YTD
-0.82%
6M
-0.19%
1Y
92.22%
3Y*
16.72%
5Y*
4.23%
10Y*
18.49%

CSCO

1D
-0.60%
1M
18.88%
YTD
58.91%
6M
57.34%
1Y
90.30%
3Y*
37.33%
5Y*
20.60%
10Y*
18.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AUPH vs. CSCO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AUPH
Aurinia Pharmaceuticals Inc.
-0.82%77.62%-0.11%108.10%-81.11%65.37%-31.74%197.07%50.55%115.71%
CSCO
Cisco Systems, Inc.
58.91%33.47%21.00%9.30%-22.46%45.76%-3.49%13.81%16.57%31.27%

Correlation

The correlation between AUPH and CSCO is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Sep 3, 2014

0.20

The correlation between AUPH and CSCO shifts across timeframes, from 0.10 (1 year) to 0.23 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AUPH:

$2.18B

CSCO:

$482.83B

EPS

AUPH:

$2.15

CSCO:

$3.00

PE Ratio

AUPH:

7.37

CSCO:

40.40

PEG Ratio

AUPH:

0.00

CSCO:

33.90

PS Ratio

AUPH:

7.37

CSCO:

7.95

PB Ratio

AUPH:

3.84

CSCO:

9.88

Total Revenue (TTM)

AUPH:

$298.30M

CSCO:

$60.75B

Gross Profit (TTM)

AUPH:

$267.70M

CSCO:

$39.08B

EBITDA (TTM)

AUPH:

$153.45M

CSCO:

$13.98B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AUPH vs. CSCO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AUPH
AUPH Risk / Return Rank: 9090
Overall Rank
AUPH Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
AUPH Sortino Ratio Rank: 8686
Sortino Ratio Rank
AUPH Omega Ratio Rank: 8888
Omega Ratio Rank
AUPH Calmar Ratio Rank: 9494
Calmar Ratio Rank
AUPH Martin Ratio Rank: 9292
Martin Ratio Rank

CSCO
CSCO Risk / Return Rank: 9595
Overall Rank
CSCO Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
CSCO Sortino Ratio Rank: 9393
Sortino Ratio Rank
CSCO Omega Ratio Rank: 9595
Omega Ratio Rank
CSCO Calmar Ratio Rank: 9595
Calmar Ratio Rank
CSCO Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AUPH vs. CSCO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and Cisco Systems, Inc. (CSCO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AUPHCSCODifference
Sharpe ratioReturn per unit of total volatility

-0.90

Sortino ratioReturn per unit of downside risk

-0.84

Omega ratioGain probability vs. loss probability

1.38

1.53

-0.15

Calmar ratioReturn relative to maximum drawdown

5.83

6.69

-0.86

Martin ratioReturn relative to average drawdown

12.68

18.37

-5.69

AUPH vs. CSCO - Sharpe Ratio Comparison

The current AUPH Sharpe Ratio is 2.04, which is lower than the CSCO Sharpe Ratio of 2.94. The chart below compares the historical Sharpe Ratios of AUPH and CSCO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AUPH vs. CSCO - Drawdown Comparison

The maximum AUPH drawdown since its inception was -87.58%, roughly equal to the maximum CSCO drawdown of -89.26%. Use the drawdown chart below to compare losses from any high point for AUPH and CSCO.


Loading charts...

Drawdown Indicators


AUPHCSCODifference

Max Drawdown

Largest peak-to-trough decline

-87.58%

-89.26%

+1.68%

Max Drawdown (1Y)

Largest decline over 1 year

-15.91%

-13.57%

-2.34%

Max Drawdown (3Y)

Largest decline over 3 years

-60.80%

-20.16%

-40.64%

Max Drawdown (5Y)

Largest decline over 5 years

-87.58%

-36.68%

-50.90%

Max Drawdown (10Y)

Largest decline over 10 years

-87.58%

-41.95%

-45.63%

Current Drawdown

Current decline from peak

-52.18%

-6.85%

-45.33%

Average Drawdown

Average peak-to-trough decline

-49.21%

-40.11%

-9.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.30%

4.93%

+2.37%

Volatility

AUPH vs. CSCO - Volatility Comparison

The current volatility for Aurinia Pharmaceuticals Inc. (AUPH) is 9.07%, while Cisco Systems, Inc. (CSCO) has a volatility of 17.31%. This indicates that AUPH experiences smaller price fluctuations and is considered to be less risky than CSCO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AUPHCSCODifference

Volatility (1M)

Calculated over the trailing 1-month period

9.07%

17.31%

-8.24%

Volatility (6M)

Calculated over the trailing 6-month period

23.92%

27.29%

-3.37%

Volatility (1Y)

Calculated over the trailing 1-year period

45.50%

30.93%

+14.57%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.46%

24.88%

+42.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.95%

25.89%

+48.06%

Dividends

AUPH vs. CSCO - Dividend Comparison

AUPH has not paid dividends to shareholders, while CSCO's dividend yield for the trailing twelve months is around 1.36%.


PositionTTM20252024202320222021202020192018201720162015
AUPH
Aurinia Pharmaceuticals Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
CSCO
Cisco Systems, Inc.
1.36%2.12%2.69%3.07%3.17%2.32%3.20%2.88%2.95%2.95%3.28%3.02%

Financials

AUPH vs. CSCO - Financials Comparison

This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and Cisco Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
77.71M
15.84B
(AUPH) Total Revenue
(CSCO) Total Revenue
Values in USD except per share items

AUPH vs. CSCO - Profitability Comparison

The chart below illustrates the profitability comparison between Aurinia Pharmaceuticals Inc. and Cisco Systems, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20222023202420252026
91.6%
63.6%
Portfolio components
AUPH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a gross profit of 71.20M and revenue of 77.71M. Therefore, the gross margin over that period was 91.6%.

CSCO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cisco Systems, Inc. reported a gross profit of 10.08B and revenue of 15.84B. Therefore, the gross margin over that period was 63.6%.

AUPH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported an operating income of 41.42M and revenue of 77.71M, resulting in an operating margin of 53.3%.

CSCO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cisco Systems, Inc. reported an operating income of 3.96B and revenue of 15.84B, resulting in an operating margin of 25.0%.

AUPH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a net income of 34.36M and revenue of 77.71M, resulting in a net margin of 44.2%.

CSCO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cisco Systems, Inc. reported a net income of 3.37B and revenue of 15.84B, resulting in a net margin of 21.3%.


Frequently Asked Questions


AUPH and CSCO have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CSCO has higher volatility (17.31%) compared to AUPH (9.07%). In terms of maximum drawdown, AUPH dropped -87.58% vs CSCO's -89.26%.

CSCO currently has the higher Sharpe Ratio (2.94 vs 2.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AUPH and CSCO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer